Intermittent fasting has been all the rage about an easy way to lose weight. This study says otherwise.

CAR-T cells ruled the oncology field for years until their CAR-NK cell counterparts showed equivalent early efficacy without the adverse events.

Immunotherapy has been focused on T cells in the last decade. Now, there is a growing interest in NK cells. Here are the fundamentals needed to understand the approach to innate immunity.

PCR testing used to classify COVID cases in the US have set their cut-off too high. This has the potential to diagnose “positive” COVID cases, even though patients may be carrying viral loads considered to be non-contagious.

Trillium Therapeutics’ latest cohort for monotherapy treatment of broad lymphoma shows promising results with a relatively clean safety profile. This data spiked the attention of Pfizer and Wall Street, providing Trillium with more than $170M to advance their pipeline forward.

The use of telemedicine skyrocketed at the beginning of COVID, as in-person visits were limited. A NYU study found that adoption has been rising among patients and healthcare providers.

Scepticism grows as scientists around the world develop their own coronavirus vaccine and administer it to themselves and others.

Public health experts fear that the immunity built up against COVID might not be enough to protect against reinfection. This complicates the development of a vaccine and leaves us at a standstill until more research comes along.